Company page

Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. (ticker: DNTH) is a public company based in the United States, with a market capitalization of approximately $4.51 billion. The company focuses on developing innovative therapies to address unmet medical needs. Dianthus is committed to advancing its pipeline and bringing new treatments to market.